Bristol Myers Squibb
Associate Director, Oncology Clinical Biomarker Asset Lead, Translational Develo
Bristol Myers Squibb, Princeton, New Jersey, us, 08543
Associate Director, Oncology Clinical Biomarker Asset Lead, Translational Development
Working with Us
Challenging, meaningful, life‑changing. At Bristol Myers Squibb, we do unusual and transformative work every day—from optimizing production lines to breakthrough cell therapies. You’ll grow and thrive through unique opportunities at an unprecedented scale, alongside high‑achieving teams. Take your career farther than you thought possible.
We recognize the importance of balance and flexibility. Our competitive benefits, services, and programs give employees the resources to pursue goals both at work and in their personal lives. Read more:
careers.bms.com/working-with-us .
Our world‑class Translational Development organization explores new aspects of tumor and immune biology to create tailored, individualized treatment strategies. We need experienced translational scientists to deepen disease biology understanding, drive biomarker strategies, and support regulatory submissions for our late‑stage clinical oncology portfolio.
Role Summary The Clinical Biomarker Asset Lead will develop and execute translational strategies in solid tumor oncology across assigned programs, acting as a lead scientist, reporting key data, and contributing to regulatory submissions. The position is based in Princeton, NJ; Summit, NJ; or Cambridge, MA.
Key Responsibilities
Integrate translational research with clinical development, delivering aligned biomarker strategies and high‑quality data packages.
Partner internally and externally to coordinate execution of translational development deliverables.
Champion and implement biomarker strategies for development projects, driving alignment with R&D portfolio goals.
Engage matrix leadership to define, revise, and progress translational biomarker plans, constantly analyzing progress and solving challenges.
Ensure biomarker plans meet project standards and support clinical operational plans.
Build productive relationships with team members and external collaborators, including scientific KOLs, to support translational goals.
Communicate biomarker program risks, milestones, and data across stakeholders.
Professional Skills
In‑depth knowledge of solid tumor oncology and the evolving clinical landscape.
Strong scientific background with publication record.
Experience with biomarker strategy implementation in early or late‑stage drug development.
Clinical protocol authoring and review of regulatory documents.
Working knowledge of technologies such as genomics, immune profiling, and flow cytometry.
Excellent data analysis, problem‑solving, and communication skills.
Leadership experience in global teams and project management.
Qualifications
Ph.D. in Oncology, Immunology, or related field.
5‑8+ years in industry, 3‑5 years in oncology/translational biomarker research.
Strong understanding of drug discovery, biomarker role in development, and oncology biology.
Required versus Preferred Qualifications
Comprehensive knowledge of drug discovery or clinical development principles.
Significant knowledge of translational research, biomarker science, and oncology disease biology.
Preferred: Regulatory submission experience for solid tumor drug approvals.
If this role interests you even if your experience isn’t a perfect match, we encourage you to apply. It could be a step toward a life‑changing career.
Compensation Overview Boston, MA – NJ salary range: $186,110 – $225,519 (FTE). U.S. locations: Princeton, NJ – $186,110 – $225,519. Compensation includes base salary, incentive cash, and stock opportunities (eligible). Final pay determined by experience and qualifications.
Benefits Medical, pharmacy, dental, vision, and wellness programs; 401(k) with company match; life insurance; disability benefits; paid time off; flexible work arrangements; and many additional employee support resources. Visit
careers.bms.com/life-at-bms
for full details.
EEO Statement BMS is dedicated to ensuring that people with disabilities can excel through a transparent recruitment process, reasonable workplace accommodations, and ongoing support. Applicants may request reasonable accommodations by contacting adastaffingsupport@bms.com. BMS strives to meet all employment discrimination laws.
#J-18808-Ljbffr
We recognize the importance of balance and flexibility. Our competitive benefits, services, and programs give employees the resources to pursue goals both at work and in their personal lives. Read more:
careers.bms.com/working-with-us .
Our world‑class Translational Development organization explores new aspects of tumor and immune biology to create tailored, individualized treatment strategies. We need experienced translational scientists to deepen disease biology understanding, drive biomarker strategies, and support regulatory submissions for our late‑stage clinical oncology portfolio.
Role Summary The Clinical Biomarker Asset Lead will develop and execute translational strategies in solid tumor oncology across assigned programs, acting as a lead scientist, reporting key data, and contributing to regulatory submissions. The position is based in Princeton, NJ; Summit, NJ; or Cambridge, MA.
Key Responsibilities
Integrate translational research with clinical development, delivering aligned biomarker strategies and high‑quality data packages.
Partner internally and externally to coordinate execution of translational development deliverables.
Champion and implement biomarker strategies for development projects, driving alignment with R&D portfolio goals.
Engage matrix leadership to define, revise, and progress translational biomarker plans, constantly analyzing progress and solving challenges.
Ensure biomarker plans meet project standards and support clinical operational plans.
Build productive relationships with team members and external collaborators, including scientific KOLs, to support translational goals.
Communicate biomarker program risks, milestones, and data across stakeholders.
Professional Skills
In‑depth knowledge of solid tumor oncology and the evolving clinical landscape.
Strong scientific background with publication record.
Experience with biomarker strategy implementation in early or late‑stage drug development.
Clinical protocol authoring and review of regulatory documents.
Working knowledge of technologies such as genomics, immune profiling, and flow cytometry.
Excellent data analysis, problem‑solving, and communication skills.
Leadership experience in global teams and project management.
Qualifications
Ph.D. in Oncology, Immunology, or related field.
5‑8+ years in industry, 3‑5 years in oncology/translational biomarker research.
Strong understanding of drug discovery, biomarker role in development, and oncology biology.
Required versus Preferred Qualifications
Comprehensive knowledge of drug discovery or clinical development principles.
Significant knowledge of translational research, biomarker science, and oncology disease biology.
Preferred: Regulatory submission experience for solid tumor drug approvals.
If this role interests you even if your experience isn’t a perfect match, we encourage you to apply. It could be a step toward a life‑changing career.
Compensation Overview Boston, MA – NJ salary range: $186,110 – $225,519 (FTE). U.S. locations: Princeton, NJ – $186,110 – $225,519. Compensation includes base salary, incentive cash, and stock opportunities (eligible). Final pay determined by experience and qualifications.
Benefits Medical, pharmacy, dental, vision, and wellness programs; 401(k) with company match; life insurance; disability benefits; paid time off; flexible work arrangements; and many additional employee support resources. Visit
careers.bms.com/life-at-bms
for full details.
EEO Statement BMS is dedicated to ensuring that people with disabilities can excel through a transparent recruitment process, reasonable workplace accommodations, and ongoing support. Applicants may request reasonable accommodations by contacting adastaffingsupport@bms.com. BMS strives to meet all employment discrimination laws.
#J-18808-Ljbffr